ChatGPT-medical use

The purpose of this study was to assess ChatGPT's ability and its potential risks in medical guidance for patients with MAFLD. The study was conducted in February 2023. We simulated the questions raised by patients with MAFLD, and tested 110 questions in six aspects, including concept, diagnosis, progression, prevention, treatment and comorbidity. Each question was submitted to ChatGPT three times. Appropriateness and consistency were evaluated. In the data set, we presented the questions and responding answers. Judgments for consistency and appropriateness and reasons were also provided.

本研究旨在评估ChatGPT针对代谢相关脂肪性肝病（MAFLD）患者开展医疗指导的能力及其潜在风险。本研究于2023年2月开展。我们模拟了MAFLD患者提出的临床问诊问题，从概念、诊断、疾病进展、预防、治疗及合并症六个维度共测试110个问题。每个问题均向ChatGPT提交三次，并对回答的恰当性与一致性进行评估。本数据集收录了全部测试问题与ChatGPT的应答内容，同时附带针对回答恰当性与一致性的判定结果及判定依据。